EGF and atrial fibrillation: These results provide an additional support to the hypothesis that AF could be used as a treatment agent for PVR by clarifying an additional mechanism of action, namely AF-induced inhibition of proliferation and migration of RPE cells through affecting EGF/EGFR/MAPK signaling pathway.